Adiponectin gene polymorphisms and acute respiratory distress syndrome susceptibility and mortality

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Ahasic, Amy M ^a   Zhao, Yang ^b   Su, Li ^c   Sheu, Chau Chyun ^d   Thompson, B Taylor ^e   Christiani, David C ^c,e  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NANJING MEDICAL UNIVERSITY   (China)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ADIPONECTIN RECEPTOR; ADIPOQ PROTEIN, HUMAN;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ADIPOQ GENE; ADIPOR1 GENE; ADIPOR2 GENE; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE PRODUCT; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROMOTER REGION; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; ACUTE DISEASE; AGED; CAUSE OF DEATH; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; STATISTICS AND NUMERICAL DATA; VERY ELDERLY;

ACUTE DISEASE; ADIPONECTIN; ADULT; AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COHORT STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, ADIPONECTIN; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 84896142605     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089170     Document Type: Article

References (40)

1. Swarbrick MM, Havel PJ (2008) Physiological, pharmacological, and nutritional regulation of circulating adiponectin concentrations in humans. Metab Syndr Relat Disord 6:87-102. (Pubitemid 351769254)
2. Garaulet M, Hernandez-Morante JJ, Perez de Heredia F, Tebar FJ (2007). Adiponectin, the controversial hormone. Public Health Nutr 10(10A)1145-1150. (Pubitemid 350085203)
3. Vendrell J, Broch M, Vilarrasa N, Molina A, Gomez JM, et al. (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes Res 12(6):962-971.
4. Tilg H, Moschen AR (2008) Role of adiponectin and PBEF/visfatin as regulators of inflammation: involvement in obesity-associated diseases. Clin Sci 114:275-288. (Pubitemid 351294003)
5. Matsumoto M, Ishikawa S, Kajii E (2008) Adiponectin and noncardiovascular death: a nested case-control study. Metabolism 57:811-818. (Pubitemid 351697912)
6. Teoh H, Quan A, Bang KW, Wang G, Lovren F, et al. (2008) Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab 295(3):E658-664.
7. Konter JM, Parker JL, Baez E, Li SZ, Ranscht B, et al. (2012) Adiponectin attenuates lipopolysaccharide-induced acute lung injury through suppression of endothelial cell activation. J Immunol 188:854-863.
8. Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, et al. (1996) cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286-289. (Pubitemid 26136463)
9. Potapov VA, Chistiakov DA, Dubinina A, Shamkhalova MS, Shestakova MV, et al. (2008) Adiponectin and adiponectin receptor gene variants in relation to type 2 diabetes and insulin resistance-related phenotypes. Rev Diabet Stud 5:28-37.
10. Yamauchi T, Kamon J, Ito Y, Tsuchida A, Yokomizo T, et al. (2003) Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 423:762-769. (Pubitemid 36735700)
11. Lau C, Muniandy S (2011) Adiponectin and resistin gene polymorphisms in association with their respective adipokine levels. Ann Hum Genet 75:370-382.
12. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595-1599 (Pubitemid 30353893)
13. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86:1930-1935. (Pubitemid 32472900)
14. Diez JJ, Iglesias P (2003) The role of novel adipocyte-derived hormone adiponectin in human disease. Eur J Endocrinol 148:293-300. (Pubitemid 36410714)
15. Chandran M, Phillips SA, Ciaraldi T, Henry RR (2003) Adiponectin: more than just another fat cell hormone? Diabetes Care 26:2442-50. (Pubitemid 36993340)
16. Walkey AJ, Rice TW, Konter J, Ouchi N, Shibata R, et al. (2010) Plasma adiponectin in critically ill subjects with acute respiratory failure. Crit Care Med 38:2329-2334.
17. Shehzad A, Iqbal W, Shehzad O, Lee YS (2012) Adiponectin: regulation of its production and its role in human diseases. Hormones (Athens) 11(1):8-20.
18. Jernas M, Olsson B, Sjoholm K, Sjogren A, Rudemo M, et al. (2009) Changes in adipose tissue gene expression and plasma levels of adipokines and acute-phase proteins in patients with critical illness. Metabolism 58:102-108.
19. Venkatesh B, Hickman I, Nisbet J, Cohen J, Prins J (2009) Changes in serum adiponectin concentrations in critical illness: a preliminary investigation. Crit Care 13:R105.
20. Koch A, Sanson E, Voigt S, Helm A, Trautwein C, et al. (2011) Serum adiponectin upon admission to the intensive care unit may predict mortality in critically ill patients. J Crit Care 26:166-174
21. Langouche L, Vander Perre S, Frystyk J, Flyvbjerg A, Hansen TK, et al. (2009) Adiponectin, retinol-binding protein 4, and leptin in protracted critical illness of pulmonary origin. Crit Care 13:R112.
22. Gong MN, Thompson BT, Williams P, Pothier L, Boyce PD, et al. (2005) Clinical predictors of mortality in acute respiratory distress syndrome: potential role of red cell transfusion. Crit Care Med 33(6): 1191-1198. (Pubitemid 40827364)
23. Frank AJ, Sheu CC, Zhao Y, Chen F, Su L, et al. (2012) BCL2 genetic variants are associated with acute kidney injury in septic shock. Crit Care Med 40:2116-2123.
24. Tejera P, Meyer N, Chen F, Feng R, Zhao Y, et al. (2012) Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin. J Med Genet 49:671-680.
25. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, et al. (2008) Concept, design and implementation of a cardiovascular gene-centric 50k SNP array for large-scale genomic association studies. PloS ONE 3:e3583.
26. Knaus WA, Wagner DP, Draper EA, Zimmerman JE, Bergner M, et al. (1991) The APACHE III prognostic system. Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 100(6): 1619-1636.
27. NIH/NHLBI (1998) Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: the evidence report. Rockville (MD): NIH publication no. 98-4083.
28. Siitonen N, Pulkkinen L, Lindstrom J, Kolehmainen M, Eriksson JG, et al. (2011) Association of ADIPOQ gene variants with body weight, type 2 diabetes and serum adiponectin concentrations: the Finnish Diabetes Prevention Study. BMC Med Genet 12:5.
29. Dhillon PK, Penney KL, Schumacher F, Rider JR, Sesso HD, et al. (2011) Cancer Epidemiol Biomarkers Prev 20:2618-2627.
30. Heid IM, Henneman P, Hicks A, Coassin S, Winkler T, et al. (2010) Clear detection of ADIPOQ locus as the major gene for plasma adiponectin: results of genome-wide association analyses including 4659 European individuals. Atherosclerosis 208:412-420.
31. Ling H, Waterworth DM, Stirnadel HA, Pollin TA, Barter PJ, et al. (2009) Genome-wide linkage and association analyses to identify genes influencing adiponectin levels: the GEMS study. Obesity 17:737-744.
32. Dastani Z, Johnson T, Kronenberg F, Nelson CP, Assimes TL, et al. (2013) The shared allelic architecture of adiponectin levels and coronary artery disease. Atherosclerosis 229:145-148.
33. Jee SH, Sull JW, Lee J, Shin C, Park J, et al. (2010) Adiponectin concentrations: a genome-wide association study. Am J Hum Genet 87:545-552.
34. Dastani Z, Hivert M, Timpson N, Perry JRB, Yuan X, et al. (2012) Novel loci for adiponectin levels and their influence on type 2 diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet 8(3):e1002607.
35. Johnson AD, Handsaker RE, Pulit S, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24(24):2938-2939.
36. Marques MB, Langouche L (2013) Endocrine, metabolic, and morphologic alterations of adipose tissue during critical illness. Crit Care Med 41:317-325.
37. Gong MN, Bajwa E, Thompson BT, Christiani DC (2010) Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 65(1): 44-50.
38. Gajic O, Dabbagh O, Park PK, Adesanya A, Chang SY, et al. (2011) Early identification of patients at risk of acute lung injury: evaluation of lung injury prediction score in a multicenter cohort study. Am J Respir Crit Care Med 183:462-270.
39. Stapleton RD, Dixon AE, Parsons PE, Ware LB, Suratt BT; NHLBI Acute Respiratory Distress Syndrome Network (2010) The association between BMI and plasma cytokine levels in patients with acute lung injury. Chest 138:568-577.
40. Yu S, Christiani DC, Thompson BT, Bajwa EK, Gong MN (2013) Role of diabetes in the development of acute respiratory distress syndrome. Crit Care Med 41(12):2720-2732.